Autoantibodies and their target antigens in Sjögren's syndrome
- PMID: 1603204
Autoantibodies and their target antigens in Sjögren's syndrome
Abstract
The subject of this review is the humoral autoimmune response in Sjögren's syndrome. Autoantibodies in this disease are primarily directed against the Ro/SS-A and La/SS-B autoantigens and against IgG (rheumatoid factor). The Ro/SS-A and La/SS-B autoantigens consist of a number of antigenic proteins coupled to small RNA molecules. These RNA-protein particles are present in all human cells and are strongly conserved throughout various species. Anti-Ro/SS-A and anti-La/SS-B autoantibodies can be detected using counter-immunoelectrophoresis, immunoblotting technique, ELISA or RNA precipitation assays. The preferred method of screening for anti-Ro/SS-A antibodies in human sera is counter-immunoelectrophoresis; anti-La/SS-B antibodies are best detected with the immunoblotting technique. Anti-Ro/SS-A antibodies are found in 60% of patients with Sjögren's syndrome, but are not specific markers for this disease. Anti-La/SS-B antibodies are present in approximately 40% of patients with Sjögren's syndrome; the only other disease where the antibody has been detected is systemic lupus erythematosus (15% positive). The origin and possible pathogenetic role of autoantibodies in Sjögren's syndrome is still unclear. Our view is that the current evidence supports a mechanism whereby autoantibodies are the product of an oligoclonal B-cell proliferation. The only instance where autoantibodies probably play a direct pathogenetic role is the occurrence of congenital heart block in the offspring of anti-Ro/SS-A and anti-La/SS-B positive mothers.
Similar articles
-
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.Arthritis Rheum. 1986 Feb;29(2):196-206. doi: 10.1002/art.1780290207. Arthritis Rheum. 1986. PMID: 3485431
-
Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays.J Rheumatol. 1997 May;24(5):860-6. J Rheumatol. 1997. PMID: 9150073
-
Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?Clin Exp Rheumatol. 1989 Mar-Apr;7(2):181-4. Clin Exp Rheumatol. 1989. PMID: 2736832
-
Ro/SS-A and La/SS-B: autoantigens in Sjögren's syndrome?Clin Rheumatol. 1995 Jul;14 Suppl 1:11-6. doi: 10.1007/BF03342632. Clin Rheumatol. 1995. PMID: 7493450 Review.
-
Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.Immunol Invest. 1993 Apr;22(3):189-203. doi: 10.3109/08820139309063402. Immunol Invest. 1993. PMID: 8509157 Review.
Cited by
-
Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. A review of autoantibody detection, autoantigen composition, autoantibody-disease associations and possible etiologic mechanisms.Rheumatol Int. 1992;12(4):129-40. doi: 10.1007/BF00274932. Rheumatol Int. 1992. PMID: 1439479 Review. No abstract available.
-
The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjögren's syndrome.Rheumatol Int. 1993;13(4):147-50. doi: 10.1007/BF00301261. Rheumatol Int. 1993. PMID: 8310206
-
Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren Syndrome.Ann Am Thorac Soc. 2016 Mar;13(3):371-5. doi: 10.1513/AnnalsATS.201511-759BC. Ann Am Thorac Soc. 2016. PMID: 26741500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials